News & Updates

For women with polycystic ovary syndrome (PCOS), if a 5-day letrozole regimen for ovulation induction does not work, extending the duration of treatment may do the job, as shown in a study.

Among patients with infective endocarditis (IE), the presence of congenital heart disease (CHD) appears to be correlated with better short- and long-term outcomes, a new study has found.

Ezetimibe plus rosuvastatin reduces liver fat in people with nonalcoholic fatty liver disease (NAFLD) in the randomized, active-controlled ESSENTIAL trial.

The use of the combination of palbociclib plus an aromatase inhibitor (AI) in the first-line treatment setting appears to confer survival advantage on patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) metastatic breast cancer (MBC), according to real-world data.

Lower levels of alpha-linolenic acid (ALA) in serum phospholipids among patients with heart failure (HF) predict a poorer prognosis relative to the highest ALA levels, a recent study has shown.